Last 12 months
Inside the activity.
2 purchase rows · 107 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 11 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 2 | 3 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 26 |
| Aug 2026 | 0 | 18 |
| Sep 2026 | 0 | 15 |
| Oct 2026 | 0 | 9 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 01, 2024 Filed Aug 5, 2024 22:31 UTC |
Hunt HazelChief Scientific Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $2.81 | $0.00 |
DisclosureSEC source: 0000950170-24-091049 · ownership.xml · derivative · entry 3 Hunt Hazel · CIK 0001698307 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2024-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully exercisable. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 22:31 UTC |
Hunt HazelChief Scientific Officer
|
Tax withholdingCommon Stock | 34,773 | $37.94 | $1,319,287.62 |
DisclosureSEC source: 0000950170-24-091049 · ownership.xml · nonDerivative · entry 2 Hunt Hazel · CIK 0001698307 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,581 F1 · kind: These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on September 11, 2024. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 22:31 UTC |
Hunt HazelChief Scientific Officer
|
Exercise / conversionCommon Stock | 60,000 | $2.81 | $168,600.00 |
DisclosureSEC source: 0000950170-24-091049 · ownership.xml · nonDerivative · entry 1 Hunt Hazel · CIK 0001698307 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,354 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 20:42 UTC |
BELANOFF JOSEPH KDirector · Chief Executive Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 450,000 | $0.00 Strike: $3.29 | $0.00 |
DisclosureSEC source: 0000950170-24-090052 · ownership.xml · derivative · entry 4 BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 450,000 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully exercisable. Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 20:42 UTC |
BELANOFF JOSEPH KDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 259,583 | $38.67 | $10,038,074.61 |
DisclosureSEC source: 0000950170-24-090052 · ownership.xml · nonDerivative · entry 2 BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 539,228 F1 · kind: These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on July 31, 2024. The options subject to the net exercise were to expire on February 18, 2025. Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 20:42 UTC |
BELANOFF JOSEPH KDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 450,000 | $3.29 | $1,480,500.00 |
DisclosureSEC source: 0000950170-24-090052 · ownership.xml · nonDerivative · entry 1 BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 798,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2024 Filed Feb 14, 2025 21:40 UTC |
BELANOFF JOSEPH KDirector · Chief Executive Officer
|
OtherCommon Stock | 190,417 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-021329 · ownership.xml · nonDerivative · entry 4 BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 Disclosed balance after: 3,022,335 F1 · kind: Transfer of shares without consideration to the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02. F2 · ownership.nature: Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. F3 · ownership.nature: Due to an administrative error, prior reporting of the name of this trust has been corrected. The exact name of the trust, "Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02" was mistakenly identified as the "Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02". Read SEC document |
| July 31, 2024 Filed Feb 14, 2025 21:40 UTC |
BELANOFF JOSEPH KDirector · Chief Executive Officer
|
GiftCommon Stock | 190,417 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-021329 · ownership.xml · nonDerivative · entry 3 BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 21:16 UTC |
Lyon Joseph DouglasSee Remarks
|
Exercise / conversionStock option (right to buy) · Derivative | 5,000 | $0.00 Strike: $11.35 | $0.00 |
DisclosureSEC source: 0000950170-24-081631 · ownership.xml · derivative · entry 3 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,167 Underlying: Common Stock · 5,000 shares Expires 2029-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully exercisable. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 21:16 UTC |
Lyon Joseph DouglasSee Remarks
|
SaleCommon Stock | 5,000 | $32.49 | $162,452.00 |
DisclosureSEC source: 0000950170-24-081631 · ownership.xml · nonDerivative · entry 2 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,290 F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction. F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $32.49 to $32.70 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. F1 · balance_after: Includes 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 507 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 21:16 UTC |
Lyon Joseph DouglasSee Remarks
|
Exercise / conversionCommon Stock | 5,000 | $11.35 | $56,750.00 |
DisclosureSEC source: 0000950170-24-081631 · ownership.xml · nonDerivative · entry 1 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 507 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 21:13 UTC |
Guyer WilliamChief Development Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 10,000 | $0.00 Strike: $21.65 | $0.00 |
DisclosureSEC source: 0000950170-24-081628 · ownership.xml · derivative · entry 3 Guyer William · CIK 0001879013 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 490,000 Underlying: Common Stock · 10,000 shares Expires 2031-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Shares subject to the stock option vested and became exercisable with respect to 25% of the shares on the first anniversary of August 16, 2021 (the "Vesting Commencement Date") with the remaining shares vesting and becoming exercisable ratably on a monthly basis over a period of 36 consecutive months thereafter until fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 21:13 UTC |
Guyer WilliamChief Development Officer
|
SaleCommon Stock | 10,000 | $32.49 | $324,900.00 |
DisclosureSEC source: 0000950170-24-081628 · ownership.xml · nonDerivative · entry 2 Guyer William · CIK 0001879013 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,039 F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. F1 · balance_after: Includes 478 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023 and 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 21:13 UTC |
Guyer WilliamChief Development Officer
|
Exercise / conversionCommon Stock | 10,000 | $21.65 | $216,500.00 |
DisclosureSEC source: 0000950170-24-081628 · ownership.xml · nonDerivative · entry 1 Guyer William · CIK 0001879013 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,039 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 478 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023 and 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 20:54 UTC |
Robb Gary CharlesChief Business Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 11,000 | $0.00 Strike: $3.29 | $0.00 |
DisclosureSEC source: 0000950170-24-081594 · ownership.xml · derivative · entry 6 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,037 Underlying: Common Stock · 11,000 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully exercisable. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 20:54 UTC |
Robb Gary CharlesChief Business Officer
|
SaleCommon Stock | 11,000 | $32.49 | $357,390.00 |
DisclosureSEC source: 0000950170-24-081594 · ownership.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,291 F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction. F1 · balance_after: Includes 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 20:54 UTC |
Robb Gary CharlesChief Business Officer
|
Exercise / conversionCommon Stock | 11,000 | $3.29 | $36,190.00 |
DisclosureSEC source: 0000950170-24-081594 · ownership.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 20:54 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 2,200 | $0.00 Strike: $5.86 | $0.00 |
DisclosureSEC source: 0000950170-24-081593 · ownership.xml · derivative · entry 3 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 150 Underlying: Common Stock · 2,200 shares Expires 2026-07-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully exercisable. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 20:54 UTC |
Swisher Daniel N JRDirector
|
SaleCommon Stock | 2,200 | $32.81 | $72,182.00 |
DisclosureSEC source: 0000950170-24-081593 · ownership.xml · nonDerivative · entry 2 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 20:54 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionCommon Stock | 2,200 | $5.86 | $12,892.00 |
DisclosureSEC source: 0000950170-24-081593 · ownership.xml · nonDerivative · entry 1 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 22:47 UTC |
Robb Gary CharlesChief Business Officer
|
GiftCommon Stock | 550 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-076962 · ownership.xml · nonDerivative · entry 5 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Custodial Account for Child Disclosed balance after: 9,250 F3 · ownership.nature: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian. Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 22:47 UTC |
Robb Gary CharlesChief Business Officer
|
GiftCommon Stock | 550 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-076962 · ownership.xml · nonDerivative · entry 4 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Custodial Account for Child Disclosed balance after: 9,250 F3 · ownership.nature: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian. Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 22:47 UTC |
Robb Gary CharlesChief Business Officer
|
GiftCommon Stock | 550 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-076962 · ownership.xml · nonDerivative · entry 3 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Custodial Account for Child Disclosed balance after: 7,250 F3 · ownership.nature: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian. Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 22:47 UTC |
Robb Gary CharlesChief Business Officer
|
OtherCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-076962 · ownership.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Custodial Account for Child Disclosed balance after: 6,700 F2 · kind: These shares were transferred from the custodial account to the child's personal account. F3 · ownership.nature: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian. Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 22:47 UTC |
Robb Gary CharlesChief Business Officer
|
GiftCommon Stock | 2,650 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-076962 · ownership.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,291 F1 · balance_after: Includes 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 22:21 UTC |
Robb Gary CharlesChief Business Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 14,000 | $0.00 Strike: $3.29 | $0.00 |
DisclosureSEC source: 0000950170-24-070045 · ownership.xml · derivative · entry 6 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,037 Underlying: Common Stock · 14,000 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully exercisable. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 22:21 UTC |
Robb Gary CharlesChief Business Officer
|
Tax withholdingCommon Stock | 8,174 | $32.87 | $268,679.38 |
DisclosureSEC source: 0000950170-24-070045 · ownership.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,941 F2 · kind: These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of options that occurred on June 4, 2024. The options subject to the net exercise were to expire on February 18, 2025. F1 · balance_after: Includes 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 22:21 UTC |
Robb Gary CharlesChief Business Officer
|
Exercise / conversionCommon Stock | 14,000 | $3.29 | $46,060.00 |
DisclosureSEC source: 0000950170-24-070045 · ownership.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:19 UTC |
Robb Gary CharlesChief Business Officer
|
GrantCommon Stock | 1,818 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-069612 · ownership.xml · nonDerivative · entry 3 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,115 F6 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. F3 · balance_after: Includes 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, and 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:19 UTC |
Robb Gary CharlesChief Business Officer
|
GrantCommon Stock | 1,818 | $31.30 | $56,903.40 |
DisclosureSEC source: 0000950170-24-069612 · ownership.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,297 F4 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on June 3, 2024. F5 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. F3 · balance_after: Includes 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, and 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:19 UTC |
Robb Gary CharlesChief Business Officer
|
Tax withholdingCommon Stock | 724 | $30.17 | $21,843.08 |
DisclosureSEC source: 0000950170-24-069612 · ownership.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,479 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. F2 · price: The closing price on May 31, 2024 was used to calculate the withholding obligation. F3 · balance_after: Includes 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, and 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:15 UTC |
Lyon Joseph DouglasSee Remarks
|
Exercise / conversionStock option (right to buy) · Derivative | 5,000 | $0.00 Strike: $11.35 | $0.00 |
DisclosureSEC source: 0000950170-24-069608 · ownership.xml · derivative · entry 6 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,167 Underlying: Common Stock · 5,000 shares Expires 2029-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Fully exercisable. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:15 UTC |
Lyon Joseph DouglasSee Remarks
|
GrantCommon Stock | 1,232 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-069608 · ownership.xml · nonDerivative · entry 5 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,290 F8 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. F1 · balance_after: Includes 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023 and 507 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:15 UTC |
Lyon Joseph DouglasSee Remarks
|
GrantCommon Stock | 1,232 | $31.30 | $38,561.60 |
DisclosureSEC source: 0000950170-24-069608 · ownership.xml · nonDerivative · entry 4 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,058 F6 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on June 3, 2024. F7 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. F1 · balance_after: Includes 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023 and 507 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:15 UTC |
Lyon Joseph DouglasSee Remarks
|
Tax withholdingCommon Stock | 488 | $30.17 | $14,722.96 |
DisclosureSEC source: 0000950170-24-069608 · ownership.xml · nonDerivative · entry 3 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,826 F4 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. F5 · price: The closing price on May 31, 2024 was used to calculate the withholding obligation. F1 · balance_after: Includes 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023 and 507 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:15 UTC |
Lyon Joseph DouglasSee Remarks
|
SaleCommon Stock | 5,000 | $30.18 | $150,916.00 |
DisclosureSEC source: 0000950170-24-069608 · ownership.xml · nonDerivative · entry 2 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,314 F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction. F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $30.17 to $30.21 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. F1 · balance_after: Includes 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023 and 507 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:15 UTC |
Lyon Joseph DouglasSee Remarks
|
Exercise / conversionCommon Stock | 5,000 | $11.35 | $56,750.00 |
DisclosureSEC source: 0000950170-24-069608 · ownership.xml · nonDerivative · entry 1 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023 and 507 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:15 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 2,200 | $0.00 Strike: $5.86 | $0.00 |
DisclosureSEC source: 0000950170-24-069607 · ownership.xml · derivative · entry 3 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,350 Underlying: Common Stock · 2,200 shares Expires 2026-07-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully exercisable. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:15 UTC |
Swisher Daniel N JRDirector
|
SaleCommon Stock | 2,200 | $30.21 | $66,462.00 |
DisclosureSEC source: 0000950170-24-069607 · ownership.xml · nonDerivative · entry 2 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:15 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionCommon Stock | 2,200 | $5.86 | $12,892.00 |
DisclosureSEC source: 0000950170-24-069607 · ownership.xml · nonDerivative · entry 1 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:13 UTC |
Maduck SeanSee Remarks
|
Tax withholdingCommon Stock | 823 | $30.17 | $24,829.91 |
DisclosureSEC source: 0000950170-24-069604 · ownership.xml · nonDerivative · entry 1 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,399 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. F2 · price: The closing price on May 31, 2024 was used to calculate the withholding obligation. F3 · balance_after: Includes 456 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 582 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023 and 636 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:11 UTC |
Guyer WilliamChief Development Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 10,000 | $0.00 Strike: $19.26 | $0.00 |
DisclosureSEC source: 0000950170-24-069600 · ownership.xml · derivative · entry 3 Guyer William · CIK 0001879013 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 10,000 shares Expires 2032-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully exercisable. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:11 UTC |
Guyer WilliamChief Development Officer
|
SaleCommon Stock | 10,000 | $32.00 | $320,000.00 |
DisclosureSEC source: 0000950170-24-069600 · ownership.xml · nonDerivative · entry 2 Guyer William · CIK 0001879013 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,039 F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. F1 · balance_after: Includes 478 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023 and 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:11 UTC |
Guyer WilliamChief Development Officer
|
Exercise / conversionCommon Stock | 10,000 | $19.26 | $192,600.00 |
DisclosureSEC source: 0000950170-24-069600 · ownership.xml · nonDerivative · entry 1 Guyer William · CIK 0001879013 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,039 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 478 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023 and 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:10 UTC |
Mokari AtabakChief Financial Officer
|
GrantCommon Stock | 1,448 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-069598 · ownership.xml · nonDerivative · entry 3 Mokari Atabak · CIK 0001678419 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,861 F6 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. F3 · balance_after: Includes 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 508 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, and 554 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:10 UTC |
Mokari AtabakChief Financial Officer
|
GrantCommon Stock | 1,448 | $31.30 | $45,322.40 |
DisclosureSEC source: 0000950170-24-069598 · ownership.xml · nonDerivative · entry 2 Mokari Atabak · CIK 0001678419 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,413 F4 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on June 3, 2024. F5 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. F3 · balance_after: Includes 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 508 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, and 554 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 01:10 UTC |
Mokari AtabakChief Financial Officer
|
Tax withholdingCommon Stock | 571 | $30.17 | $17,227.07 |
DisclosureSEC source: 0000950170-24-069598 · ownership.xml · nonDerivative · entry 1 Mokari Atabak · CIK 0001678419 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,965 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. F2 · price: The closing price on May 31, 2024 was used to calculate the withholding obligation. F3 · balance_after: Includes 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 508 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, and 554 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| May 28, 2024 Filed May 31, 2024 00:03 UTC |
Guyer WilliamChief Development Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $19.26 | $0.00 |
DisclosureSEC source: 0000950170-24-066881 · ownership.xml · derivative · entry 3 Guyer William · CIK 0001879013 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 30,000 shares Expires 2032-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully exercisable. Read SEC document |
| May 28, 2024 Filed May 31, 2024 00:03 UTC |
Guyer WilliamChief Development Officer
|
SaleCommon Stock | 30,000 | $32.00 | $960,000.00 |
DisclosureSEC source: 0000950170-24-066881 · ownership.xml · nonDerivative · entry 2 Guyer William · CIK 0001879013 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,039 F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. F1 · balance_after: Includes 478 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023 and 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| May 28, 2024 Filed May 31, 2024 00:03 UTC |
Guyer WilliamChief Development Officer
|
Exercise / conversionCommon Stock | 30,000 | $19.26 | $577,800.00 |
DisclosureSEC source: 0000950170-24-066881 · ownership.xml · nonDerivative · entry 1 Guyer William · CIK 0001879013 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,039 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 478 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023 and 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.